IT1250367B - Materiale proteico legante anticorpi contro il citomegalovirus umano e reagenti diagnostici derivati da tale materiale proteico. - Google Patents

Materiale proteico legante anticorpi contro il citomegalovirus umano e reagenti diagnostici derivati da tale materiale proteico.

Info

Publication number
IT1250367B
IT1250367B ITTO911020A ITTO911020A IT1250367B IT 1250367 B IT1250367 B IT 1250367B IT TO911020 A ITTO911020 A IT TO911020A IT TO911020 A ITTO911020 A IT TO911020A IT 1250367 B IT1250367 B IT 1250367B
Authority
IT
Italy
Prior art keywords
protein material
hcmv
protein
human cytomegalovirus
antibody binding
Prior art date
Application number
ITTO911020A
Other languages
English (en)
Inventor
Alessandro Ripalti
Maria Paola Landini
Placa Michele La
Original Assignee
Consiglio Nazi0Nale Delle Rice
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Consiglio Nazi0Nale Delle Rice filed Critical Consiglio Nazi0Nale Delle Rice
Priority to ITTO911020A priority Critical patent/IT1250367B/it
Publication of ITTO911020A0 publication Critical patent/ITTO911020A0/it
Publication of ITTO911020A1 publication Critical patent/ITTO911020A1/it
Application granted granted Critical
Publication of IT1250367B publication Critical patent/IT1250367B/it

Links

Landscapes

  • Peptides Or Proteins (AREA)

Abstract

Materiale proteico consistente in un peptide sintetico definente un determinante antigenico della proteina pp150 del Citomegalovirus umano (HCMV), in particolare la sequenza carbossil-terminale degli ultimi 40 amminoacidi della proteina pp150; il peptide risulta fortemente reattivo sia verso IgM che verso IgG umane prodotte contro tale Citomegalovirus e viene utilizzato, associato con antigeni tradizionali (HCMV parzialmente purificati o cellule infette) e/o con altri peptidi sintetici o con proteine di fusione, come reagente antigenico in un kit ELISA o in "dot blot" su supporto solido di nitrocellulosa per la ricerca di IgG e IgM HCMV-specifiche, oppure per la produzione di sieri policlonali monospecifici e/o di MaB anti-HCMV da utilizzare in kit diagnostici per la ricerca diretta del virus.
ITTO911020A 1991-12-23 1991-12-23 Materiale proteico legante anticorpi contro il citomegalovirus umano e reagenti diagnostici derivati da tale materiale proteico. IT1250367B (it)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ITTO911020A IT1250367B (it) 1991-12-23 1991-12-23 Materiale proteico legante anticorpi contro il citomegalovirus umano e reagenti diagnostici derivati da tale materiale proteico.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITTO911020A IT1250367B (it) 1991-12-23 1991-12-23 Materiale proteico legante anticorpi contro il citomegalovirus umano e reagenti diagnostici derivati da tale materiale proteico.

Publications (3)

Publication Number Publication Date
ITTO911020A0 ITTO911020A0 (it) 1991-12-23
ITTO911020A1 ITTO911020A1 (it) 1993-06-23
IT1250367B true IT1250367B (it) 1995-04-07

Family

ID=11409822

Family Applications (1)

Application Number Title Priority Date Filing Date
ITTO911020A IT1250367B (it) 1991-12-23 1991-12-23 Materiale proteico legante anticorpi contro il citomegalovirus umano e reagenti diagnostici derivati da tale materiale proteico.

Country Status (1)

Country Link
IT (1) IT1250367B (it)

Also Published As

Publication number Publication date
ITTO911020A1 (it) 1993-06-23
ITTO911020A0 (it) 1991-12-23

Similar Documents

Publication Publication Date Title
AU1273695A (en) Monoclonal antibodies specific for phf-tau, hybridomas secreting them, antigen recognition by these antibodies and their applications
AU8849391A (en) An augmented western blot format and immunoassay for detection of viral antibodies
IT1266740B1 (it) Materiale proteico ricombinante legante anticorpi contro il citomegalovirus umano, reagenti diagnostici derivati da tale
AU5479396A (en) Epstein-Barr virus peptides and antibodies against these peptides
DK187286A (da) Herpes-virus-specifikke immunologiske materialer og metoder
AU7737091A (en) Immunodiagnostic assay for rheumatoid arthritis
AU7211591A (en) Immunologically active peptides or polypeptides from the parvovirus b19
WO1995016040A3 (en) Immunofluorescence assay for the detection of antibodies using recombinant antigens in insoluble form
AU4439993A (en) HCV peptide antigens and method of determining HCV
AU638155B2 (en) Peptides with a characteristic antigenic determinant for alphal-microglobulin
IT1250367B (it) Materiale proteico legante anticorpi contro il citomegalovirus umano e reagenti diagnostici derivati da tale materiale proteico.
CA2120342A1 (en) Epstein-barr virus peptides and antibodies against these peptides
IT1250366B (it) Materiale proteico ricombinante legante anticorpi contro il cigalomegavirus umano, reagenti diagnostici derivati da tale materialeproteico e plasmide ricombinante esprimente lo stesso.
Maine et al. The DNA-binding protein pUL57 of human cytomegalovirus: comparison of specific immunoglobulin M (IgM) reactivity with IgM reactivity to other major target antigens
EP0985931A3 (en) Recombinant antigen immunoassay for the diagnosis of syphilis
EP0754755A3 (de) Rekombinante autologe Fusionsproteine des Epstein-Barr-Virus, diese enthaltende Testkits und Verfahren zum Nachweis von Epstein-Barr-Virus-spezifischen Antikörpern
EP0428629A4 (en) Synthetic polypeptides and antibodies related to epstein-barr virus nuclear antigen
WO1999038886A1 (en) Peptide structures and their use in diagnosis of herpes simplex virus type 2
EP0687308A4 (en) RECOMBINANT CAPSIDANTIGENT OF THE EPSTEIN-BARR VIRUSES, WHICH IS USEFUL IN A DIAGNOSTIC METHOD
WO2023164428A8 (en) Recombinant antibodies comprising anti-human immunoglobulin g-invertase fusion proteins and methods of using the same
Kühn et al. The use of Western blot procedures in the analysis of herpes simplex virus proteins
Boriskin et al. Epitope analysis of mumps virus proteins in a persistent cell culture infection: changes in the hemagglutinin-neuraminidase polypeptide
CA2074370A1 (en) Synthetic antigens for the detection of antibodies to hepatitis c virus

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19971218